|
Market Closed -
NYSE
16:02:34 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 1,417.54 USD | +3.19% |
|
+11.31% | +31.90% |
| 10-30 | S&P 500 Slips Weekly as Underwhelming Hyperscaler Results Offset Anthropic's IPO Boost | MT |
| 10-30 | Eli Lilly Seen Sustaining Obesity Growth, UBS Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ELI LILLY AND COMPANY | Other Pharmaceuticals | +3.19% | +11.31% | +31.90% | +67.86% | +456.42% | 1,263B |  | | |
- Stock Market
- Stocks
- LLY Stock
- Charts Eli Lilly and Company
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
